Global Custom Peptide CDMO Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Custom Peptide CDMO Services market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Custom Peptide CDMO (Contract Development and Manufacturing Organization) services refer to the outsourcing of peptide synthesis, development, and manufacturing processes to specialized companies. These services are provided by organizations with expertise in peptide chemistry, production, and quality control, helping pharmaceutical companies, biotech firms, and research institutions develop and produce peptides for various applications.
This report is a detailed and comprehensive analysis for global Custom Peptide CDMO Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Custom Peptide CDMO Services market size and forecasts, in consumption value ($ Million), 2021-2032
Global Custom Peptide CDMO Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Custom Peptide CDMO Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Custom Peptide CDMO Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Custom Peptide CDMO Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Custom Peptide CDMO Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bachem, CordenPharma, PolyPeptide, AmbioPharm, Genscript, Thermo Fisher, USV Peptides, Bio Basic, ScinoPharm, JPT, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Custom Peptide CDMO Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Custom Peptide CDMO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Custom Peptide CDMO Services, with revenue, gross margin, and global market share of Custom Peptide CDMO Services from 2021 to 2026.
Chapter 3, the Custom Peptide CDMO Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Custom Peptide CDMO Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Custom Peptide CDMO Services.
Chapter 13, to describe Custom Peptide CDMO Services research findings and conclusion.
Custom Peptide CDMO (Contract Development and Manufacturing Organization) services refer to the outsourcing of peptide synthesis, development, and manufacturing processes to specialized companies. These services are provided by organizations with expertise in peptide chemistry, production, and quality control, helping pharmaceutical companies, biotech firms, and research institutions develop and produce peptides for various applications.
This report is a detailed and comprehensive analysis for global Custom Peptide CDMO Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Custom Peptide CDMO Services market size and forecasts, in consumption value ($ Million), 2021-2032
Global Custom Peptide CDMO Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Custom Peptide CDMO Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Custom Peptide CDMO Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Custom Peptide CDMO Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Custom Peptide CDMO Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bachem, CordenPharma, PolyPeptide, AmbioPharm, Genscript, Thermo Fisher, USV Peptides, Bio Basic, ScinoPharm, JPT, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Custom Peptide CDMO Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- GMP Services
- Non-GMP Services
- Commercial
- Scientific Research
- Other
- Bachem
- CordenPharma
- PolyPeptide
- AmbioPharm
- Genscript
- Thermo Fisher
- USV Peptides
- Bio Basic
- ScinoPharm
- JPT
- CBL
- Piramal Pharma
- CPC Scientific
- Creative Peptides
- Chinese Peptide Company
- ChengDu ShengNuo Biotec
- AppTec Co., Ltd.
- GL Biochem
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Custom Peptide CDMO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Custom Peptide CDMO Services, with revenue, gross margin, and global market share of Custom Peptide CDMO Services from 2021 to 2026.
Chapter 3, the Custom Peptide CDMO Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Custom Peptide CDMO Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Custom Peptide CDMO Services.
Chapter 13, to describe Custom Peptide CDMO Services research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Custom Peptide CDMO Services by Type
1.3.1 Overview: Global Custom Peptide CDMO Services Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Custom Peptide CDMO Services Consumption Value Market Share by Type in 2025
1.3.3 GMP Services
1.3.4 Non-GMP Services
1.4 Global Custom Peptide CDMO Services Market by Application
1.4.1 Overview: Global Custom Peptide CDMO Services Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Commercial
1.4.3 Scientific Research
1.4.4 Other
1.5 Global Custom Peptide CDMO Services Market Size & Forecast
1.6 Global Custom Peptide CDMO Services Market Size and Forecast by Region
1.6.1 Global Custom Peptide CDMO Services Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Custom Peptide CDMO Services Market Size by Region, (2021-2032)
1.6.3 North America Custom Peptide CDMO Services Market Size and Prospect (2021-2032)
1.6.4 Europe Custom Peptide CDMO Services Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Custom Peptide CDMO Services Market Size and Prospect (2021-2032)
1.6.6 South America Custom Peptide CDMO Services Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Custom Peptide CDMO Services Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Bachem
2.1.1 Bachem Details
2.1.2 Bachem Major Business
2.1.3 Bachem Custom Peptide CDMO Services Product and Solutions
2.1.4 Bachem Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Bachem Recent Developments and Future Plans
2.2 CordenPharma
2.2.1 CordenPharma Details
2.2.2 CordenPharma Major Business
2.2.3 CordenPharma Custom Peptide CDMO Services Product and Solutions
2.2.4 CordenPharma Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 CordenPharma Recent Developments and Future Plans
2.3 PolyPeptide
2.3.1 PolyPeptide Details
2.3.2 PolyPeptide Major Business
2.3.3 PolyPeptide Custom Peptide CDMO Services Product and Solutions
2.3.4 PolyPeptide Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 PolyPeptide Recent Developments and Future Plans
2.4 AmbioPharm
2.4.1 AmbioPharm Details
2.4.2 AmbioPharm Major Business
2.4.3 AmbioPharm Custom Peptide CDMO Services Product and Solutions
2.4.4 AmbioPharm Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 AmbioPharm Recent Developments and Future Plans
2.5 Genscript
2.5.1 Genscript Details
2.5.2 Genscript Major Business
2.5.3 Genscript Custom Peptide CDMO Services Product and Solutions
2.5.4 Genscript Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Genscript Recent Developments and Future Plans
2.6 Thermo Fisher
2.6.1 Thermo Fisher Details
2.6.2 Thermo Fisher Major Business
2.6.3 Thermo Fisher Custom Peptide CDMO Services Product and Solutions
2.6.4 Thermo Fisher Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Thermo Fisher Recent Developments and Future Plans
2.7 USV Peptides
2.7.1 USV Peptides Details
2.7.2 USV Peptides Major Business
2.7.3 USV Peptides Custom Peptide CDMO Services Product and Solutions
2.7.4 USV Peptides Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 USV Peptides Recent Developments and Future Plans
2.8 Bio Basic
2.8.1 Bio Basic Details
2.8.2 Bio Basic Major Business
2.8.3 Bio Basic Custom Peptide CDMO Services Product and Solutions
2.8.4 Bio Basic Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Bio Basic Recent Developments and Future Plans
2.9 ScinoPharm
2.9.1 ScinoPharm Details
2.9.2 ScinoPharm Major Business
2.9.3 ScinoPharm Custom Peptide CDMO Services Product and Solutions
2.9.4 ScinoPharm Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 ScinoPharm Recent Developments and Future Plans
2.10 JPT
2.10.1 JPT Details
2.10.2 JPT Major Business
2.10.3 JPT Custom Peptide CDMO Services Product and Solutions
2.10.4 JPT Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 JPT Recent Developments and Future Plans
2.11 CBL
2.11.1 CBL Details
2.11.2 CBL Major Business
2.11.3 CBL Custom Peptide CDMO Services Product and Solutions
2.11.4 CBL Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 CBL Recent Developments and Future Plans
2.12 Piramal Pharma
2.12.1 Piramal Pharma Details
2.12.2 Piramal Pharma Major Business
2.12.3 Piramal Pharma Custom Peptide CDMO Services Product and Solutions
2.12.4 Piramal Pharma Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Piramal Pharma Recent Developments and Future Plans
2.13 CPC Scientific
2.13.1 CPC Scientific Details
2.13.2 CPC Scientific Major Business
2.13.3 CPC Scientific Custom Peptide CDMO Services Product and Solutions
2.13.4 CPC Scientific Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 CPC Scientific Recent Developments and Future Plans
2.14 Creative Peptides
2.14.1 Creative Peptides Details
2.14.2 Creative Peptides Major Business
2.14.3 Creative Peptides Custom Peptide CDMO Services Product and Solutions
2.14.4 Creative Peptides Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Creative Peptides Recent Developments and Future Plans
2.15 Chinese Peptide Company
2.15.1 Chinese Peptide Company Details
2.15.2 Chinese Peptide Company Major Business
2.15.3 Chinese Peptide Company Custom Peptide CDMO Services Product and Solutions
2.15.4 Chinese Peptide Company Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Chinese Peptide Company Recent Developments and Future Plans
2.16 ChengDu ShengNuo Biotec
2.16.1 ChengDu ShengNuo Biotec Details
2.16.2 ChengDu ShengNuo Biotec Major Business
2.16.3 ChengDu ShengNuo Biotec Custom Peptide CDMO Services Product and Solutions
2.16.4 ChengDu ShengNuo Biotec Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 ChengDu ShengNuo Biotec Recent Developments and Future Plans
2.17 AppTec Co., Ltd.
2.17.1 AppTec Co., Ltd. Details
2.17.2 AppTec Co., Ltd. Major Business
2.17.3 AppTec Co., Ltd. Custom Peptide CDMO Services Product and Solutions
2.17.4 AppTec Co., Ltd. Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 AppTec Co., Ltd. Recent Developments and Future Plans
2.18 GL Biochem
2.18.1 GL Biochem Details
2.18.2 GL Biochem Major Business
2.18.3 GL Biochem Custom Peptide CDMO Services Product and Solutions
2.18.4 GL Biochem Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 GL Biochem Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Custom Peptide CDMO Services Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Custom Peptide CDMO Services by Company Revenue
3.2.2 Top 3 Custom Peptide CDMO Services Players Market Share in 2025
3.2.3 Top 6 Custom Peptide CDMO Services Players Market Share in 2025
3.3 Custom Peptide CDMO Services Market: Overall Company Footprint Analysis
3.3.1 Custom Peptide CDMO Services Market: Region Footprint
3.3.2 Custom Peptide CDMO Services Market: Company Product Type Footprint
3.3.3 Custom Peptide CDMO Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Custom Peptide CDMO Services Consumption Value and Market Share by Type (2021-2026)
4.2 Global Custom Peptide CDMO Services Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Custom Peptide CDMO Services Consumption Value Market Share by Application (2021-2026)
5.2 Global Custom Peptide CDMO Services Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Custom Peptide CDMO Services Consumption Value by Type (2021-2032)
6.2 North America Custom Peptide CDMO Services Market Size by Application (2021-2032)
6.3 North America Custom Peptide CDMO Services Market Size by Country
6.3.1 North America Custom Peptide CDMO Services Consumption Value by Country (2021-2032)
6.3.2 United States Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
6.3.3 Canada Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
6.3.4 Mexico Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Custom Peptide CDMO Services Consumption Value by Type (2021-2032)
7.2 Europe Custom Peptide CDMO Services Consumption Value by Application (2021-2032)
7.3 Europe Custom Peptide CDMO Services Market Size by Country
7.3.1 Europe Custom Peptide CDMO Services Consumption Value by Country (2021-2032)
7.3.2 Germany Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
7.3.3 France Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
7.3.5 Russia Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
7.3.6 Italy Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Custom Peptide CDMO Services Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Custom Peptide CDMO Services Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Custom Peptide CDMO Services Market Size by Region
8.3.1 Asia-Pacific Custom Peptide CDMO Services Consumption Value by Region (2021-2032)
8.3.2 China Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
8.3.3 Japan Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
8.3.4 South Korea Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
8.3.5 India Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
8.3.7 Australia Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Custom Peptide CDMO Services Consumption Value by Type (2021-2032)
9.2 South America Custom Peptide CDMO Services Consumption Value by Application (2021-2032)
9.3 South America Custom Peptide CDMO Services Market Size by Country
9.3.1 South America Custom Peptide CDMO Services Consumption Value by Country (2021-2032)
9.3.2 Brazil Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
9.3.3 Argentina Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Custom Peptide CDMO Services Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Custom Peptide CDMO Services Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Custom Peptide CDMO Services Market Size by Country
10.3.1 Middle East & Africa Custom Peptide CDMO Services Consumption Value by Country (2021-2032)
10.3.2 Turkey Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
10.3.4 UAE Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Custom Peptide CDMO Services Market Drivers
11.2 Custom Peptide CDMO Services Market Restraints
11.3 Custom Peptide CDMO Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Custom Peptide CDMO Services Industry Chain
12.2 Custom Peptide CDMO Services Upstream Analysis
12.3 Custom Peptide CDMO Services Midstream Analysis
12.4 Custom Peptide CDMO Services Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Custom Peptide CDMO Services by Type
1.3.1 Overview: Global Custom Peptide CDMO Services Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Custom Peptide CDMO Services Consumption Value Market Share by Type in 2025
1.3.3 GMP Services
1.3.4 Non-GMP Services
1.4 Global Custom Peptide CDMO Services Market by Application
1.4.1 Overview: Global Custom Peptide CDMO Services Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Commercial
1.4.3 Scientific Research
1.4.4 Other
1.5 Global Custom Peptide CDMO Services Market Size & Forecast
1.6 Global Custom Peptide CDMO Services Market Size and Forecast by Region
1.6.1 Global Custom Peptide CDMO Services Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Custom Peptide CDMO Services Market Size by Region, (2021-2032)
1.6.3 North America Custom Peptide CDMO Services Market Size and Prospect (2021-2032)
1.6.4 Europe Custom Peptide CDMO Services Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Custom Peptide CDMO Services Market Size and Prospect (2021-2032)
1.6.6 South America Custom Peptide CDMO Services Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Custom Peptide CDMO Services Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Bachem
2.1.1 Bachem Details
2.1.2 Bachem Major Business
2.1.3 Bachem Custom Peptide CDMO Services Product and Solutions
2.1.4 Bachem Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Bachem Recent Developments and Future Plans
2.2 CordenPharma
2.2.1 CordenPharma Details
2.2.2 CordenPharma Major Business
2.2.3 CordenPharma Custom Peptide CDMO Services Product and Solutions
2.2.4 CordenPharma Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 CordenPharma Recent Developments and Future Plans
2.3 PolyPeptide
2.3.1 PolyPeptide Details
2.3.2 PolyPeptide Major Business
2.3.3 PolyPeptide Custom Peptide CDMO Services Product and Solutions
2.3.4 PolyPeptide Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 PolyPeptide Recent Developments and Future Plans
2.4 AmbioPharm
2.4.1 AmbioPharm Details
2.4.2 AmbioPharm Major Business
2.4.3 AmbioPharm Custom Peptide CDMO Services Product and Solutions
2.4.4 AmbioPharm Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 AmbioPharm Recent Developments and Future Plans
2.5 Genscript
2.5.1 Genscript Details
2.5.2 Genscript Major Business
2.5.3 Genscript Custom Peptide CDMO Services Product and Solutions
2.5.4 Genscript Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Genscript Recent Developments and Future Plans
2.6 Thermo Fisher
2.6.1 Thermo Fisher Details
2.6.2 Thermo Fisher Major Business
2.6.3 Thermo Fisher Custom Peptide CDMO Services Product and Solutions
2.6.4 Thermo Fisher Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Thermo Fisher Recent Developments and Future Plans
2.7 USV Peptides
2.7.1 USV Peptides Details
2.7.2 USV Peptides Major Business
2.7.3 USV Peptides Custom Peptide CDMO Services Product and Solutions
2.7.4 USV Peptides Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 USV Peptides Recent Developments and Future Plans
2.8 Bio Basic
2.8.1 Bio Basic Details
2.8.2 Bio Basic Major Business
2.8.3 Bio Basic Custom Peptide CDMO Services Product and Solutions
2.8.4 Bio Basic Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Bio Basic Recent Developments and Future Plans
2.9 ScinoPharm
2.9.1 ScinoPharm Details
2.9.2 ScinoPharm Major Business
2.9.3 ScinoPharm Custom Peptide CDMO Services Product and Solutions
2.9.4 ScinoPharm Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 ScinoPharm Recent Developments and Future Plans
2.10 JPT
2.10.1 JPT Details
2.10.2 JPT Major Business
2.10.3 JPT Custom Peptide CDMO Services Product and Solutions
2.10.4 JPT Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 JPT Recent Developments and Future Plans
2.11 CBL
2.11.1 CBL Details
2.11.2 CBL Major Business
2.11.3 CBL Custom Peptide CDMO Services Product and Solutions
2.11.4 CBL Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 CBL Recent Developments and Future Plans
2.12 Piramal Pharma
2.12.1 Piramal Pharma Details
2.12.2 Piramal Pharma Major Business
2.12.3 Piramal Pharma Custom Peptide CDMO Services Product and Solutions
2.12.4 Piramal Pharma Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Piramal Pharma Recent Developments and Future Plans
2.13 CPC Scientific
2.13.1 CPC Scientific Details
2.13.2 CPC Scientific Major Business
2.13.3 CPC Scientific Custom Peptide CDMO Services Product and Solutions
2.13.4 CPC Scientific Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 CPC Scientific Recent Developments and Future Plans
2.14 Creative Peptides
2.14.1 Creative Peptides Details
2.14.2 Creative Peptides Major Business
2.14.3 Creative Peptides Custom Peptide CDMO Services Product and Solutions
2.14.4 Creative Peptides Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Creative Peptides Recent Developments and Future Plans
2.15 Chinese Peptide Company
2.15.1 Chinese Peptide Company Details
2.15.2 Chinese Peptide Company Major Business
2.15.3 Chinese Peptide Company Custom Peptide CDMO Services Product and Solutions
2.15.4 Chinese Peptide Company Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Chinese Peptide Company Recent Developments and Future Plans
2.16 ChengDu ShengNuo Biotec
2.16.1 ChengDu ShengNuo Biotec Details
2.16.2 ChengDu ShengNuo Biotec Major Business
2.16.3 ChengDu ShengNuo Biotec Custom Peptide CDMO Services Product and Solutions
2.16.4 ChengDu ShengNuo Biotec Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 ChengDu ShengNuo Biotec Recent Developments and Future Plans
2.17 AppTec Co., Ltd.
2.17.1 AppTec Co., Ltd. Details
2.17.2 AppTec Co., Ltd. Major Business
2.17.3 AppTec Co., Ltd. Custom Peptide CDMO Services Product and Solutions
2.17.4 AppTec Co., Ltd. Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 AppTec Co., Ltd. Recent Developments and Future Plans
2.18 GL Biochem
2.18.1 GL Biochem Details
2.18.2 GL Biochem Major Business
2.18.3 GL Biochem Custom Peptide CDMO Services Product and Solutions
2.18.4 GL Biochem Custom Peptide CDMO Services Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 GL Biochem Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Custom Peptide CDMO Services Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Custom Peptide CDMO Services by Company Revenue
3.2.2 Top 3 Custom Peptide CDMO Services Players Market Share in 2025
3.2.3 Top 6 Custom Peptide CDMO Services Players Market Share in 2025
3.3 Custom Peptide CDMO Services Market: Overall Company Footprint Analysis
3.3.1 Custom Peptide CDMO Services Market: Region Footprint
3.3.2 Custom Peptide CDMO Services Market: Company Product Type Footprint
3.3.3 Custom Peptide CDMO Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Custom Peptide CDMO Services Consumption Value and Market Share by Type (2021-2026)
4.2 Global Custom Peptide CDMO Services Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Custom Peptide CDMO Services Consumption Value Market Share by Application (2021-2026)
5.2 Global Custom Peptide CDMO Services Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Custom Peptide CDMO Services Consumption Value by Type (2021-2032)
6.2 North America Custom Peptide CDMO Services Market Size by Application (2021-2032)
6.3 North America Custom Peptide CDMO Services Market Size by Country
6.3.1 North America Custom Peptide CDMO Services Consumption Value by Country (2021-2032)
6.3.2 United States Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
6.3.3 Canada Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
6.3.4 Mexico Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Custom Peptide CDMO Services Consumption Value by Type (2021-2032)
7.2 Europe Custom Peptide CDMO Services Consumption Value by Application (2021-2032)
7.3 Europe Custom Peptide CDMO Services Market Size by Country
7.3.1 Europe Custom Peptide CDMO Services Consumption Value by Country (2021-2032)
7.3.2 Germany Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
7.3.3 France Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
7.3.5 Russia Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
7.3.6 Italy Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Custom Peptide CDMO Services Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Custom Peptide CDMO Services Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Custom Peptide CDMO Services Market Size by Region
8.3.1 Asia-Pacific Custom Peptide CDMO Services Consumption Value by Region (2021-2032)
8.3.2 China Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
8.3.3 Japan Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
8.3.4 South Korea Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
8.3.5 India Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
8.3.7 Australia Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Custom Peptide CDMO Services Consumption Value by Type (2021-2032)
9.2 South America Custom Peptide CDMO Services Consumption Value by Application (2021-2032)
9.3 South America Custom Peptide CDMO Services Market Size by Country
9.3.1 South America Custom Peptide CDMO Services Consumption Value by Country (2021-2032)
9.3.2 Brazil Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
9.3.3 Argentina Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Custom Peptide CDMO Services Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Custom Peptide CDMO Services Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Custom Peptide CDMO Services Market Size by Country
10.3.1 Middle East & Africa Custom Peptide CDMO Services Consumption Value by Country (2021-2032)
10.3.2 Turkey Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
10.3.4 UAE Custom Peptide CDMO Services Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Custom Peptide CDMO Services Market Drivers
11.2 Custom Peptide CDMO Services Market Restraints
11.3 Custom Peptide CDMO Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Custom Peptide CDMO Services Industry Chain
12.2 Custom Peptide CDMO Services Upstream Analysis
12.3 Custom Peptide CDMO Services Midstream Analysis
12.4 Custom Peptide CDMO Services Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Custom Peptide CDMO Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Custom Peptide CDMO Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Custom Peptide CDMO Services Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Custom Peptide CDMO Services Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Bachem Company Information, Head Office, and Major Competitors
Table 6. Bachem Major Business
Table 7. Bachem Custom Peptide CDMO Services Product and Solutions
Table 8. Bachem Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Bachem Recent Developments and Future Plans
Table 10. CordenPharma Company Information, Head Office, and Major Competitors
Table 11. CordenPharma Major Business
Table 12. CordenPharma Custom Peptide CDMO Services Product and Solutions
Table 13. CordenPharma Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. CordenPharma Recent Developments and Future Plans
Table 15. PolyPeptide Company Information, Head Office, and Major Competitors
Table 16. PolyPeptide Major Business
Table 17. PolyPeptide Custom Peptide CDMO Services Product and Solutions
Table 18. PolyPeptide Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. AmbioPharm Company Information, Head Office, and Major Competitors
Table 20. AmbioPharm Major Business
Table 21. AmbioPharm Custom Peptide CDMO Services Product and Solutions
Table 22. AmbioPharm Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. AmbioPharm Recent Developments and Future Plans
Table 24. Genscript Company Information, Head Office, and Major Competitors
Table 25. Genscript Major Business
Table 26. Genscript Custom Peptide CDMO Services Product and Solutions
Table 27. Genscript Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Genscript Recent Developments and Future Plans
Table 29. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 30. Thermo Fisher Major Business
Table 31. Thermo Fisher Custom Peptide CDMO Services Product and Solutions
Table 32. Thermo Fisher Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Thermo Fisher Recent Developments and Future Plans
Table 34. USV Peptides Company Information, Head Office, and Major Competitors
Table 35. USV Peptides Major Business
Table 36. USV Peptides Custom Peptide CDMO Services Product and Solutions
Table 37. USV Peptides Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. USV Peptides Recent Developments and Future Plans
Table 39. Bio Basic Company Information, Head Office, and Major Competitors
Table 40. Bio Basic Major Business
Table 41. Bio Basic Custom Peptide CDMO Services Product and Solutions
Table 42. Bio Basic Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Bio Basic Recent Developments and Future Plans
Table 44. ScinoPharm Company Information, Head Office, and Major Competitors
Table 45. ScinoPharm Major Business
Table 46. ScinoPharm Custom Peptide CDMO Services Product and Solutions
Table 47. ScinoPharm Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. ScinoPharm Recent Developments and Future Plans
Table 49. JPT Company Information, Head Office, and Major Competitors
Table 50. JPT Major Business
Table 51. JPT Custom Peptide CDMO Services Product and Solutions
Table 52. JPT Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. JPT Recent Developments and Future Plans
Table 54. CBL Company Information, Head Office, and Major Competitors
Table 55. CBL Major Business
Table 56. CBL Custom Peptide CDMO Services Product and Solutions
Table 57. CBL Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. CBL Recent Developments and Future Plans
Table 59. Piramal Pharma Company Information, Head Office, and Major Competitors
Table 60. Piramal Pharma Major Business
Table 61. Piramal Pharma Custom Peptide CDMO Services Product and Solutions
Table 62. Piramal Pharma Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. Piramal Pharma Recent Developments and Future Plans
Table 64. CPC Scientific Company Information, Head Office, and Major Competitors
Table 65. CPC Scientific Major Business
Table 66. CPC Scientific Custom Peptide CDMO Services Product and Solutions
Table 67. CPC Scientific Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. CPC Scientific Recent Developments and Future Plans
Table 69. Creative Peptides Company Information, Head Office, and Major Competitors
Table 70. Creative Peptides Major Business
Table 71. Creative Peptides Custom Peptide CDMO Services Product and Solutions
Table 72. Creative Peptides Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. Creative Peptides Recent Developments and Future Plans
Table 74. Chinese Peptide Company Company Information, Head Office, and Major Competitors
Table 75. Chinese Peptide Company Major Business
Table 76. Chinese Peptide Company Custom Peptide CDMO Services Product and Solutions
Table 77. Chinese Peptide Company Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Chinese Peptide Company Recent Developments and Future Plans
Table 79. ChengDu ShengNuo Biotec Company Information, Head Office, and Major Competitors
Table 80. ChengDu ShengNuo Biotec Major Business
Table 81. ChengDu ShengNuo Biotec Custom Peptide CDMO Services Product and Solutions
Table 82. ChengDu ShengNuo Biotec Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. ChengDu ShengNuo Biotec Recent Developments and Future Plans
Table 84. AppTec Co., Ltd. Company Information, Head Office, and Major Competitors
Table 85. AppTec Co., Ltd. Major Business
Table 86. AppTec Co., Ltd. Custom Peptide CDMO Services Product and Solutions
Table 87. AppTec Co., Ltd. Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 88. AppTec Co., Ltd. Recent Developments and Future Plans
Table 89. GL Biochem Company Information, Head Office, and Major Competitors
Table 90. GL Biochem Major Business
Table 91. GL Biochem Custom Peptide CDMO Services Product and Solutions
Table 92. GL Biochem Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 93. GL Biochem Recent Developments and Future Plans
Table 94. Global Custom Peptide CDMO Services Revenue (USD Million) by Players (2021-2026)
Table 95. Global Custom Peptide CDMO Services Revenue Share by Players (2021-2026)
Table 96. Breakdown of Custom Peptide CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 97. Market Position of Players in Custom Peptide CDMO Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 98. Head Office of Key Custom Peptide CDMO Services Players
Table 99. Custom Peptide CDMO Services Market: Company Product Type Footprint
Table 100. Custom Peptide CDMO Services Market: Company Product Application Footprint
Table 101. Custom Peptide CDMO Services New Market Entrants and Barriers to Market Entry
Table 102. Custom Peptide CDMO Services Mergers, Acquisition, Agreements, and Collaborations
Table 103. Global Custom Peptide CDMO Services Consumption Value (USD Million) by Type (2021-2026)
Table 104. Global Custom Peptide CDMO Services Consumption Value Share by Type (2021-2026)
Table 105. Global Custom Peptide CDMO Services Consumption Value Forecast by Type (2027-2032)
Table 106. Global Custom Peptide CDMO Services Consumption Value by Application (2021-2026)
Table 107. Global Custom Peptide CDMO Services Consumption Value Forecast by Application (2027-2032)
Table 108. North America Custom Peptide CDMO Services Consumption Value by Type (2021-2026) & (USD Million)
Table 109. North America Custom Peptide CDMO Services Consumption Value by Type (2027-2032) & (USD Million)
Table 110. North America Custom Peptide CDMO Services Consumption Value by Application (2021-2026) & (USD Million)
Table 111. North America Custom Peptide CDMO Services Consumption Value by Application (2027-2032) & (USD Million)
Table 112. North America Custom Peptide CDMO Services Consumption Value by Country (2021-2026) & (USD Million)
Table 113. North America Custom Peptide CDMO Services Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Europe Custom Peptide CDMO Services Consumption Value by Type (2021-2026) & (USD Million)
Table 115. Europe Custom Peptide CDMO Services Consumption Value by Type (2027-2032) & (USD Million)
Table 116. Europe Custom Peptide CDMO Services Consumption Value by Application (2021-2026) & (USD Million)
Table 117. Europe Custom Peptide CDMO Services Consumption Value by Application (2027-2032) & (USD Million)
Table 118. Europe Custom Peptide CDMO Services Consumption Value by Country (2021-2026) & (USD Million)
Table 119. Europe Custom Peptide CDMO Services Consumption Value by Country (2027-2032) & (USD Million)
Table 120. Asia-Pacific Custom Peptide CDMO Services Consumption Value by Type (2021-2026) & (USD Million)
Table 121. Asia-Pacific Custom Peptide CDMO Services Consumption Value by Type (2027-2032) & (USD Million)
Table 122. Asia-Pacific Custom Peptide CDMO Services Consumption Value by Application (2021-2026) & (USD Million)
Table 123. Asia-Pacific Custom Peptide CDMO Services Consumption Value by Application (2027-2032) & (USD Million)
Table 124. Asia-Pacific Custom Peptide CDMO Services Consumption Value by Region (2021-2026) & (USD Million)
Table 125. Asia-Pacific Custom Peptide CDMO Services Consumption Value by Region (2027-2032) & (USD Million)
Table 126. South America Custom Peptide CDMO Services Consumption Value by Type (2021-2026) & (USD Million)
Table 127. South America Custom Peptide CDMO Services Consumption Value by Type (2027-2032) & (USD Million)
Table 128. South America Custom Peptide CDMO Services Consumption Value by Application (2021-2026) & (USD Million)
Table 129. South America Custom Peptide CDMO Services Consumption Value by Application (2027-2032) & (USD Million)
Table 130. South America Custom Peptide CDMO Services Consumption Value by Country (2021-2026) & (USD Million)
Table 131. South America Custom Peptide CDMO Services Consumption Value by Country (2027-2032) & (USD Million)
Table 132. Middle East & Africa Custom Peptide CDMO Services Consumption Value by Type (2021-2026) & (USD Million)
Table 133. Middle East & Africa Custom Peptide CDMO Services Consumption Value by Type (2027-2032) & (USD Million)
Table 134. Middle East & Africa Custom Peptide CDMO Services Consumption Value by Application (2021-2026) & (USD Million)
Table 135. Middle East & Africa Custom Peptide CDMO Services Consumption Value by Application (2027-2032) & (USD Million)
Table 136. Middle East & Africa Custom Peptide CDMO Services Consumption Value by Country (2021-2026) & (USD Million)
Table 137. Middle East & Africa Custom Peptide CDMO Services Consumption Value by Country (2027-2032) & (USD Million)
Table 138. Global Key Players of Custom Peptide CDMO Services Upstream (Raw Materials)
Table 139. Global Custom Peptide CDMO Services Typical Customers
Table 1. Global Custom Peptide CDMO Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Custom Peptide CDMO Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Custom Peptide CDMO Services Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Custom Peptide CDMO Services Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Bachem Company Information, Head Office, and Major Competitors
Table 6. Bachem Major Business
Table 7. Bachem Custom Peptide CDMO Services Product and Solutions
Table 8. Bachem Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Bachem Recent Developments and Future Plans
Table 10. CordenPharma Company Information, Head Office, and Major Competitors
Table 11. CordenPharma Major Business
Table 12. CordenPharma Custom Peptide CDMO Services Product and Solutions
Table 13. CordenPharma Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. CordenPharma Recent Developments and Future Plans
Table 15. PolyPeptide Company Information, Head Office, and Major Competitors
Table 16. PolyPeptide Major Business
Table 17. PolyPeptide Custom Peptide CDMO Services Product and Solutions
Table 18. PolyPeptide Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. AmbioPharm Company Information, Head Office, and Major Competitors
Table 20. AmbioPharm Major Business
Table 21. AmbioPharm Custom Peptide CDMO Services Product and Solutions
Table 22. AmbioPharm Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. AmbioPharm Recent Developments and Future Plans
Table 24. Genscript Company Information, Head Office, and Major Competitors
Table 25. Genscript Major Business
Table 26. Genscript Custom Peptide CDMO Services Product and Solutions
Table 27. Genscript Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Genscript Recent Developments and Future Plans
Table 29. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 30. Thermo Fisher Major Business
Table 31. Thermo Fisher Custom Peptide CDMO Services Product and Solutions
Table 32. Thermo Fisher Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Thermo Fisher Recent Developments and Future Plans
Table 34. USV Peptides Company Information, Head Office, and Major Competitors
Table 35. USV Peptides Major Business
Table 36. USV Peptides Custom Peptide CDMO Services Product and Solutions
Table 37. USV Peptides Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. USV Peptides Recent Developments and Future Plans
Table 39. Bio Basic Company Information, Head Office, and Major Competitors
Table 40. Bio Basic Major Business
Table 41. Bio Basic Custom Peptide CDMO Services Product and Solutions
Table 42. Bio Basic Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Bio Basic Recent Developments and Future Plans
Table 44. ScinoPharm Company Information, Head Office, and Major Competitors
Table 45. ScinoPharm Major Business
Table 46. ScinoPharm Custom Peptide CDMO Services Product and Solutions
Table 47. ScinoPharm Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. ScinoPharm Recent Developments and Future Plans
Table 49. JPT Company Information, Head Office, and Major Competitors
Table 50. JPT Major Business
Table 51. JPT Custom Peptide CDMO Services Product and Solutions
Table 52. JPT Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. JPT Recent Developments and Future Plans
Table 54. CBL Company Information, Head Office, and Major Competitors
Table 55. CBL Major Business
Table 56. CBL Custom Peptide CDMO Services Product and Solutions
Table 57. CBL Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. CBL Recent Developments and Future Plans
Table 59. Piramal Pharma Company Information, Head Office, and Major Competitors
Table 60. Piramal Pharma Major Business
Table 61. Piramal Pharma Custom Peptide CDMO Services Product and Solutions
Table 62. Piramal Pharma Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. Piramal Pharma Recent Developments and Future Plans
Table 64. CPC Scientific Company Information, Head Office, and Major Competitors
Table 65. CPC Scientific Major Business
Table 66. CPC Scientific Custom Peptide CDMO Services Product and Solutions
Table 67. CPC Scientific Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. CPC Scientific Recent Developments and Future Plans
Table 69. Creative Peptides Company Information, Head Office, and Major Competitors
Table 70. Creative Peptides Major Business
Table 71. Creative Peptides Custom Peptide CDMO Services Product and Solutions
Table 72. Creative Peptides Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. Creative Peptides Recent Developments and Future Plans
Table 74. Chinese Peptide Company Company Information, Head Office, and Major Competitors
Table 75. Chinese Peptide Company Major Business
Table 76. Chinese Peptide Company Custom Peptide CDMO Services Product and Solutions
Table 77. Chinese Peptide Company Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Chinese Peptide Company Recent Developments and Future Plans
Table 79. ChengDu ShengNuo Biotec Company Information, Head Office, and Major Competitors
Table 80. ChengDu ShengNuo Biotec Major Business
Table 81. ChengDu ShengNuo Biotec Custom Peptide CDMO Services Product and Solutions
Table 82. ChengDu ShengNuo Biotec Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. ChengDu ShengNuo Biotec Recent Developments and Future Plans
Table 84. AppTec Co., Ltd. Company Information, Head Office, and Major Competitors
Table 85. AppTec Co., Ltd. Major Business
Table 86. AppTec Co., Ltd. Custom Peptide CDMO Services Product and Solutions
Table 87. AppTec Co., Ltd. Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 88. AppTec Co., Ltd. Recent Developments and Future Plans
Table 89. GL Biochem Company Information, Head Office, and Major Competitors
Table 90. GL Biochem Major Business
Table 91. GL Biochem Custom Peptide CDMO Services Product and Solutions
Table 92. GL Biochem Custom Peptide CDMO Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 93. GL Biochem Recent Developments and Future Plans
Table 94. Global Custom Peptide CDMO Services Revenue (USD Million) by Players (2021-2026)
Table 95. Global Custom Peptide CDMO Services Revenue Share by Players (2021-2026)
Table 96. Breakdown of Custom Peptide CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 97. Market Position of Players in Custom Peptide CDMO Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 98. Head Office of Key Custom Peptide CDMO Services Players
Table 99. Custom Peptide CDMO Services Market: Company Product Type Footprint
Table 100. Custom Peptide CDMO Services Market: Company Product Application Footprint
Table 101. Custom Peptide CDMO Services New Market Entrants and Barriers to Market Entry
Table 102. Custom Peptide CDMO Services Mergers, Acquisition, Agreements, and Collaborations
Table 103. Global Custom Peptide CDMO Services Consumption Value (USD Million) by Type (2021-2026)
Table 104. Global Custom Peptide CDMO Services Consumption Value Share by Type (2021-2026)
Table 105. Global Custom Peptide CDMO Services Consumption Value Forecast by Type (2027-2032)
Table 106. Global Custom Peptide CDMO Services Consumption Value by Application (2021-2026)
Table 107. Global Custom Peptide CDMO Services Consumption Value Forecast by Application (2027-2032)
Table 108. North America Custom Peptide CDMO Services Consumption Value by Type (2021-2026) & (USD Million)
Table 109. North America Custom Peptide CDMO Services Consumption Value by Type (2027-2032) & (USD Million)
Table 110. North America Custom Peptide CDMO Services Consumption Value by Application (2021-2026) & (USD Million)
Table 111. North America Custom Peptide CDMO Services Consumption Value by Application (2027-2032) & (USD Million)
Table 112. North America Custom Peptide CDMO Services Consumption Value by Country (2021-2026) & (USD Million)
Table 113. North America Custom Peptide CDMO Services Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Europe Custom Peptide CDMO Services Consumption Value by Type (2021-2026) & (USD Million)
Table 115. Europe Custom Peptide CDMO Services Consumption Value by Type (2027-2032) & (USD Million)
Table 116. Europe Custom Peptide CDMO Services Consumption Value by Application (2021-2026) & (USD Million)
Table 117. Europe Custom Peptide CDMO Services Consumption Value by Application (2027-2032) & (USD Million)
Table 118. Europe Custom Peptide CDMO Services Consumption Value by Country (2021-2026) & (USD Million)
Table 119. Europe Custom Peptide CDMO Services Consumption Value by Country (2027-2032) & (USD Million)
Table 120. Asia-Pacific Custom Peptide CDMO Services Consumption Value by Type (2021-2026) & (USD Million)
Table 121. Asia-Pacific Custom Peptide CDMO Services Consumption Value by Type (2027-2032) & (USD Million)
Table 122. Asia-Pacific Custom Peptide CDMO Services Consumption Value by Application (2021-2026) & (USD Million)
Table 123. Asia-Pacific Custom Peptide CDMO Services Consumption Value by Application (2027-2032) & (USD Million)
Table 124. Asia-Pacific Custom Peptide CDMO Services Consumption Value by Region (2021-2026) & (USD Million)
Table 125. Asia-Pacific Custom Peptide CDMO Services Consumption Value by Region (2027-2032) & (USD Million)
Table 126. South America Custom Peptide CDMO Services Consumption Value by Type (2021-2026) & (USD Million)
Table 127. South America Custom Peptide CDMO Services Consumption Value by Type (2027-2032) & (USD Million)
Table 128. South America Custom Peptide CDMO Services Consumption Value by Application (2021-2026) & (USD Million)
Table 129. South America Custom Peptide CDMO Services Consumption Value by Application (2027-2032) & (USD Million)
Table 130. South America Custom Peptide CDMO Services Consumption Value by Country (2021-2026) & (USD Million)
Table 131. South America Custom Peptide CDMO Services Consumption Value by Country (2027-2032) & (USD Million)
Table 132. Middle East & Africa Custom Peptide CDMO Services Consumption Value by Type (2021-2026) & (USD Million)
Table 133. Middle East & Africa Custom Peptide CDMO Services Consumption Value by Type (2027-2032) & (USD Million)
Table 134. Middle East & Africa Custom Peptide CDMO Services Consumption Value by Application (2021-2026) & (USD Million)
Table 135. Middle East & Africa Custom Peptide CDMO Services Consumption Value by Application (2027-2032) & (USD Million)
Table 136. Middle East & Africa Custom Peptide CDMO Services Consumption Value by Country (2021-2026) & (USD Million)
Table 137. Middle East & Africa Custom Peptide CDMO Services Consumption Value by Country (2027-2032) & (USD Million)
Table 138. Global Key Players of Custom Peptide CDMO Services Upstream (Raw Materials)
Table 139. Global Custom Peptide CDMO Services Typical Customers
LIST OF FIGURES
Figure 1. Custom Peptide CDMO Services Picture
Figure 2. Global Custom Peptide CDMO Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Custom Peptide CDMO Services Consumption Value Market Share by Type in 2025
Figure 4. GMP Services
Figure 5. Non-GMP Services
Figure 6. Global Custom Peptide CDMO Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Custom Peptide CDMO Services Consumption Value Market Share by Application in 2025
Figure 8. Commercial Picture
Figure 9. Scientific Research Picture
Figure 10. Other Picture
Figure 11. Global Custom Peptide CDMO Services Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Custom Peptide CDMO Services Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Market Custom Peptide CDMO Services Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 14. Global Custom Peptide CDMO Services Consumption Value Market Share by Region (2021-2032)
Figure 15. Global Custom Peptide CDMO Services Consumption Value Market Share by Region in 2025
Figure 16. North America Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 17. Europe Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 18. Asia-Pacific Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 19. South America Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Middle East & Africa Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global Custom Peptide CDMO Services Revenue Share by Players in 2025
Figure 23. Custom Peptide CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 24. Market Share of Custom Peptide CDMO Services by Player Revenue in 2025
Figure 25. Top 3 Custom Peptide CDMO Services Players Market Share in 2025
Figure 26. Top 6 Custom Peptide CDMO Services Players Market Share in 2025
Figure 27. Global Custom Peptide CDMO Services Consumption Value Share by Type (2021-2026)
Figure 28. Global Custom Peptide CDMO Services Market Share Forecast by Type (2027-2032)
Figure 29. Global Custom Peptide CDMO Services Consumption Value Share by Application (2021-2026)
Figure 30. Global Custom Peptide CDMO Services Market Share Forecast by Application (2027-2032)
Figure 31. North America Custom Peptide CDMO Services Consumption Value Market Share by Type (2021-2032)
Figure 32. North America Custom Peptide CDMO Services Consumption Value Market Share by Application (2021-2032)
Figure 33. North America Custom Peptide CDMO Services Consumption Value Market Share by Country (2021-2032)
Figure 34. United States Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 35. Canada Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 36. Mexico Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 37. Europe Custom Peptide CDMO Services Consumption Value Market Share by Type (2021-2032)
Figure 38. Europe Custom Peptide CDMO Services Consumption Value Market Share by Application (2021-2032)
Figure 39. Europe Custom Peptide CDMO Services Consumption Value Market Share by Country (2021-2032)
Figure 40. Germany Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 41. France Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 42. United Kingdom Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 43. Russia Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 44. Italy Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 45. Asia-Pacific Custom Peptide CDMO Services Consumption Value Market Share by Type (2021-2032)
Figure 46. Asia-Pacific Custom Peptide CDMO Services Consumption Value Market Share by Application (2021-2032)
Figure 47. Asia-Pacific Custom Peptide CDMO Services Consumption Value Market Share by Region (2021-2032)
Figure 48. China Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 49. Japan Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 50. South Korea Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 51. India Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 52. Southeast Asia Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 53. Australia Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 54. South America Custom Peptide CDMO Services Consumption Value Market Share by Type (2021-2032)
Figure 55. South America Custom Peptide CDMO Services Consumption Value Market Share by Application (2021-2032)
Figure 56. South America Custom Peptide CDMO Services Consumption Value Market Share by Country (2021-2032)
Figure 57. Brazil Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 58. Argentina Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 59. Middle East & Africa Custom Peptide CDMO Services Consumption Value Market Share by Type (2021-2032)
Figure 60. Middle East & Africa Custom Peptide CDMO Services Consumption Value Market Share by Application (2021-2032)
Figure 61. Middle East & Africa Custom Peptide CDMO Services Consumption Value Market Share by Country (2021-2032)
Figure 62. Turkey Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 63. Saudi Arabia Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 64. UAE Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 65. Custom Peptide CDMO Services Market Drivers
Figure 66. Custom Peptide CDMO Services Market Restraints
Figure 67. Custom Peptide CDMO Services Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Custom Peptide CDMO Services Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Custom Peptide CDMO Services Picture
Figure 2. Global Custom Peptide CDMO Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Custom Peptide CDMO Services Consumption Value Market Share by Type in 2025
Figure 4. GMP Services
Figure 5. Non-GMP Services
Figure 6. Global Custom Peptide CDMO Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Custom Peptide CDMO Services Consumption Value Market Share by Application in 2025
Figure 8. Commercial Picture
Figure 9. Scientific Research Picture
Figure 10. Other Picture
Figure 11. Global Custom Peptide CDMO Services Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Custom Peptide CDMO Services Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Market Custom Peptide CDMO Services Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 14. Global Custom Peptide CDMO Services Consumption Value Market Share by Region (2021-2032)
Figure 15. Global Custom Peptide CDMO Services Consumption Value Market Share by Region in 2025
Figure 16. North America Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 17. Europe Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 18. Asia-Pacific Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 19. South America Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Middle East & Africa Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global Custom Peptide CDMO Services Revenue Share by Players in 2025
Figure 23. Custom Peptide CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 24. Market Share of Custom Peptide CDMO Services by Player Revenue in 2025
Figure 25. Top 3 Custom Peptide CDMO Services Players Market Share in 2025
Figure 26. Top 6 Custom Peptide CDMO Services Players Market Share in 2025
Figure 27. Global Custom Peptide CDMO Services Consumption Value Share by Type (2021-2026)
Figure 28. Global Custom Peptide CDMO Services Market Share Forecast by Type (2027-2032)
Figure 29. Global Custom Peptide CDMO Services Consumption Value Share by Application (2021-2026)
Figure 30. Global Custom Peptide CDMO Services Market Share Forecast by Application (2027-2032)
Figure 31. North America Custom Peptide CDMO Services Consumption Value Market Share by Type (2021-2032)
Figure 32. North America Custom Peptide CDMO Services Consumption Value Market Share by Application (2021-2032)
Figure 33. North America Custom Peptide CDMO Services Consumption Value Market Share by Country (2021-2032)
Figure 34. United States Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 35. Canada Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 36. Mexico Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 37. Europe Custom Peptide CDMO Services Consumption Value Market Share by Type (2021-2032)
Figure 38. Europe Custom Peptide CDMO Services Consumption Value Market Share by Application (2021-2032)
Figure 39. Europe Custom Peptide CDMO Services Consumption Value Market Share by Country (2021-2032)
Figure 40. Germany Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 41. France Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 42. United Kingdom Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 43. Russia Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 44. Italy Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 45. Asia-Pacific Custom Peptide CDMO Services Consumption Value Market Share by Type (2021-2032)
Figure 46. Asia-Pacific Custom Peptide CDMO Services Consumption Value Market Share by Application (2021-2032)
Figure 47. Asia-Pacific Custom Peptide CDMO Services Consumption Value Market Share by Region (2021-2032)
Figure 48. China Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 49. Japan Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 50. South Korea Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 51. India Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 52. Southeast Asia Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 53. Australia Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 54. South America Custom Peptide CDMO Services Consumption Value Market Share by Type (2021-2032)
Figure 55. South America Custom Peptide CDMO Services Consumption Value Market Share by Application (2021-2032)
Figure 56. South America Custom Peptide CDMO Services Consumption Value Market Share by Country (2021-2032)
Figure 57. Brazil Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 58. Argentina Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 59. Middle East & Africa Custom Peptide CDMO Services Consumption Value Market Share by Type (2021-2032)
Figure 60. Middle East & Africa Custom Peptide CDMO Services Consumption Value Market Share by Application (2021-2032)
Figure 61. Middle East & Africa Custom Peptide CDMO Services Consumption Value Market Share by Country (2021-2032)
Figure 62. Turkey Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 63. Saudi Arabia Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 64. UAE Custom Peptide CDMO Services Consumption Value (2021-2032) & (USD Million)
Figure 65. Custom Peptide CDMO Services Market Drivers
Figure 66. Custom Peptide CDMO Services Market Restraints
Figure 67. Custom Peptide CDMO Services Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Custom Peptide CDMO Services Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
